Kainos Laboratories, Inc. operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kainos Laboratories with three other
pharmaceutical manufacturers in Asia:
China Regenerative Medicine International Ltd
of Hong Kong
sales of 356.99 million Hong Kong Dollars [US$45.71 million]
(2.67 billion Indian Rupees [US$41.50 million]
I'rom Group Co Ltd
(4.89 billion Japanese Yen [US$44.01 million]
of which 74%
was Smo Business).
During the year ended March of 2017, sales at
Kainos Laboratories were ¥4.70 billion (US$42.33 million).
decrease of 12.0%
versus 2016, when the company's sales were ¥5.35 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Kainos Laboratories had sales
of ¥4.86 billion.